Incannex Healthcare (IXHL) Accounts Payables (2020 - 2026)
Incannex Healthcare (IXHL) posted Accounts Payables of $1.6 million for Q1 2026, up 30.67% sequentially from $1.2 million in Q4 2025, and up 54.19% YoY from $1.0 million in Q1 2025.
Incannex Healthcare (IXHL) Accounts Payables (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Accounts Payables for 7 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Accounts Payables rose 54.19% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 54.19% YoY) and the FY2025 annual result came in at $6.1 million, up 1052.56% from the prior year.
- Accounts Payables climbed to $1.6 million in Q1 2026 per IXHL's latest filing, from $1.2 million in the prior quarter.
- Over five years, Accounts Payables peaked at $6.1 million in Q2 2025 and troughed at $527000.0 in Q2 2024.
- A 5-year average of $1.7 million and a median of $1.3 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables slumped 69.85% in 2024, then jumped 1052.56% in 2025.
- Over 5 years, Accounts Payables stood at $1.1 million in 2022, then soared by 82.58% to $2.0 million in 2023, then plunged by 58.09% to $818000.0 in 2024, then jumped by 49.88% to $1.2 million in 2025, then surged by 30.67% to $1.6 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.6 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 356.00 Mn |
| 10 | Incannex Healthcare | 42.23 Mn | 42.23 Mn | - | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 818,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 527,000.00 |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 955,006.00 |